case_images: PMC10805932_01
case_images: Panels (A) and (B) depict the patient's T-cell lymphoblastic leukemia cutis at the time of disease progression.
case_images: gr1.jpg
case_images: PMC10805932_01_gr1.jpg
case_images: fig0001
case_images: At the start of cycle 1 of nelarabine, the patient reported new, hive-like lesions on his face and scalp that initially mildly improved with ongoing nelarabine, but then continued to progress to his face, back and extremities (Fig. 1(A) and (B)).
case_images: Panels (A) and (B) depict the patient's skin lesions following treatment with decitabine and venetoclax.
case_images: gr2.jpg
case_images: PMC10805932_01_gr2.jpg
case_images: fig0002
case_images: By day 6 of treatment, lesions were nearly resolved, simply reduced to flat, violaceous discoloration (Fig. 2(A) and (B)).